{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:39:59Z","timestamp":1768343999321,"version":"3.49.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T00:00:00Z","timestamp":1542758400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100000833","name":"The Rosetrees trust","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3,1]]},"DOI":"10.1093\/rheumatology\/key327","type":"journal-article","created":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T15:13:09Z","timestamp":1539616389000},"page":"527-535","source":"Crossref","is-referenced-by-count":23,"title":["Methyl cap binding protein 2: a key epigenetic protein in systemic sclerosis"],"prefix":"10.1093","volume":"58","author":[{"given":"John","family":"Henderson","sequence":"first","affiliation":[{"name":"Faculty of Health and Life Sciences, Northumbria University, Newcastle Upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Max","family":"Brown","sequence":"additional","affiliation":[{"name":"Faculty of Health and Life Sciences, Northumbria University, Newcastle Upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Horsburgh","sequence":"additional","affiliation":[{"name":"Faculty of Health and Life Sciences, Northumbria University, Newcastle Upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Duffy","sequence":"additional","affiliation":[{"name":"Faculty of Health and Life Sciences, Northumbria University, Newcastle Upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Wilkinson","sequence":"additional","affiliation":[{"name":"Faculty of Health and Life Sciences, Northumbria University, Newcastle Upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Worrell","sequence":"additional","affiliation":[{"name":"Fibrosis Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle Upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Stratton","sequence":"additional","affiliation":[{"name":"Centre for Rheumatology and Connective Tissue Diseases, Royal Free Hospital, Division of Medicine, University College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"O\u2019Reilly","sequence":"additional","affiliation":[{"name":"Faculty of Health and Life Sciences, Northumbria University, Newcastle Upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,11,20]]},"reference":[{"key":"key\n\t\t\t\t2019022006303550800_key327-B1","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nrrheum.2011.149","article-title":"Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities","volume":"8","author":"Bhattacharyya","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"key\n\t\t\t\t2019022006303550800_key327-B2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1172\/JCI31139","article-title":"Systemic sclerosis: a prototypic multisystem fibrotic disorder","volume":"117","author":"Varga","year":"2007","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019022006303550800_key327-B3","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1042\/CS20130367","article-title":"Innate immunity in systemic sclerosis pathogenesis","volume":"126","author":"O\u2019Reilly","year":"2014","journal-title":"Clin Sci"},{"key":"key\n\t\t\t\t2019022006303550800_key327-B4","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cell.2007.02.006","article-title":"Epigenetics: a landscape takes shape","volume":"128","author":"Goldberg","year":"2007","journal-title":"Cell"},{"key":"key\n\t\t\t\t2019022006303550800_key327-B5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1155\/2016\/9607946","article-title":"Epigenetic modulation as a therapeutic prospect for treatment of autoimmune rheumatic diseases","volume":"2016","author":"Ciechomska","year":"2016","journal-title":"Mediators Inflamm"},{"key":"key\n\t\t\t\t2019022006303550800_key327-B6","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/gene.2014.44","article-title":"Emerging role of epigenetics in systemic sclerosis pathogenesis","volume":"15","author":"Ciechomska","year":"2014","journal-title":"Genes Immun"},{"key":"key\n\t\t\t\t2019022006303550800_key327-B7","article-title":"Epigenetic modulation as a therapy in systemic sclerosis","author":"O\u2019Reilly","year":"2018","journal-title":"Rheumatology"},{"key":"key\n\t\t\t\t2019022006303550800_key327-B8","doi-asserted-by":"crossref","first-page":"25066","DOI":"10.1038\/srep25066","article-title":"IL-13 mediates collagen deposition via STAT6 and microRNA-135b: a role for epigenetics","volume":"6","author":"O\u2019Reilly","year":"2016","journal-title":"Sci Rep"},{"key":"key\n\t\t\t\t2019022006303550800_key327-B9","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1136\/annrheumdis-2012-203194","article-title":"The Wnt antagonists DKK1 and SFRP1 are downregulated by promoter hypermethylation in systemic sclerosis","volume":"73","author":"Dees","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t2019022006303550800_key327-B10","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/30764","article-title":"Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex","volume":"393","author":"Nan","year":"1998","journal-title":"Nature"},{"key":"key\n\t\t\t\t2019022006303550800_key327-B11","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0092-8674(00)81887-5","article-title":"MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin","volume":"88","author":"Nan","year":"1997","journal-title":"Cell"},{"key":"key\n\t\t\t\t2019022006303550800_key327-B12","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1136\/annrheumdis-2014-205303","article-title":"Genome-wide DNA methylation analysis in dermal fibroblasts from patients with diffuse and limited systemic sclerosis reveals common and subset-specific DNA methylation aberrancies","volume":"74","author":"Altorok","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t2019022006303550800_key327-B13","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1042\/CS20150697","article-title":"Epigenetic regulation of cyclooxygenase-2 by methylation of c8orf4 in pulmonary fibrosis","volume":"130","author":"Evans Iona","year":"2016","journal-title":"Clin Sci"},{"key":"key\n\t\t\t\t2019022006303550800_key327-B14","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2009.10.002","article-title":"MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis","volume":"138","author":"Mann","year":"2010","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t2019022006303550800_key327-B15","doi-asserted-by":"crossref","first-page":"e0156111","DOI":"10.1371\/journal.pone.0156111","article-title":"Wnt pathway stabilizes MeCP2 protein to repress PPAR-\u03b3 in activation of hepatic stellate cells","volume":"11","author":"Kweon","year":"2016","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019022006303550800_key327-B16","doi-asserted-by":"crossref","first-page":"ra84","DOI":"10.1126\/scisignal.2004592","article-title":"Oxidative DNA damage induces the ATM-mediated transcriptional suppression of the Wnt inhibitor WIF-1 in systemic sclerosis and fibrosis","volume":"7","author":"Svegliati","year":"2014","journal-title":"Sci Signal"},{"key":"key\n\t\t\t\t2019022006303550800_key327-B17","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/13810","article-title":"Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2","volume":"23","author":"Amir","year":"1999","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t2019022006303550800_key327-B18","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/art.21948","article-title":"Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts","volume":"54","author":"Youngqing","year":"2006","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t2019022006303550800_key327-B19","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/carcin\/bgr105","article-title":"Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development","volume":"32","author":"Zhang","year":"2011","journal-title":"Carcinogenesis"},{"key":"key\n\t\t\t\t2019022006303550800_key327-B20","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.kint.2016.01.029","article-title":"Silencing of microRNA-132 reduces renal fibrosis by selectively inhibiting myofibroblast proliferation","volume":"89","author":"Bijkerk","year":"2016","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t2019022006303550800_key327-B21","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1136\/annrheumdis-2012-202742","article-title":"New insight on the Xq28 association with systemic sclerosis","volume":"72","author":"Carmona","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t2019022006303550800_key327-B22","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1002\/art.30312","article-title":"Canonical Wnt signaling induces skin fibrosis and subcutaneous lipoatrophy: a novel mouse model for scleroderma?","volume":"63","author":"Wei","year":"2011","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t2019022006303550800_key327-B23","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1136\/annrheumdis-2012-202544","article-title":"Blockade of canonical Wnt signalling ameliorates experimental dermal fibrosis","volume":"72","author":"Beyer","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t2019022006303550800_key327-B24","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.tox.2011.10.011","article-title":"MeCP2 controls the expression of RASAL1 in the hepatic fibrosis in rats","volume":"290","author":"Tao","year":"2011","journal-title":"Toxicology"},{"key":"key\n\t\t\t\t2019022006303550800_key327-B25","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/annrheumdis-2011-200568","article-title":"\u03b2-catenin is a central mediator of pro-fibrotic Wnt signaling in systemic sclerosis","volume":"71","author":"Beyer","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t2019022006303550800_key327-B26","doi-asserted-by":"crossref","first-page":"6323","DOI":"10.1038\/sj.onc.1208777","article-title":"Transcriptional silencing of secreted frizzled related protein 1 (SFRP1) by promoter hypermethylation in non-small-cell lung cancer","volume":"24","author":"Fukui","year":"2005","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t2019022006303550800_key327-B27","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1471-2407-7-126","article-title":"Down-regulation of SFRP1 as a putative tumor suppressor gene can contribute to human hepatocellular carcinoma","volume":"7","author":"Huang","year":"2007","journal-title":"BMC Cancer"},{"key":"key\n\t\t\t\t2019022006303550800_key327-B28","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1158\/1078-0432.CCR-07-0143","article-title":"Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma","volume":"13","author":"Gumz","year":"2007","journal-title":"Clin Cancer Res"},{"key":"key\n\t\t\t\t2019022006303550800_key327-B29","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.leukres.2010.04.013","article-title":"Transcriptional down-regulation of the Wnt antagonist SFRP1 in haematopoietic cells of patients with different risk types of MDS","volume":"34","author":"Reins","year":"2010","journal-title":"Leuk Res"},{"key":"key\n\t\t\t\t2019022006303550800_key327-B30","first-page":"S11","article-title":"A dual role of SFRP1 in lung fibrosis","volume":"109","author":"Burgstaller","year":"2016","journal-title":"QJM"},{"key":"key\n\t\t\t\t2019022006303550800_key327-B31","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1161\/CIRCHEARTFAILURE.114.001274","article-title":"Loss of secreted frizzled-related protein-1 leads to deterioration of cardiac function in mice and plays a role in human cardiomyopathy","volume":"8","author":"Sklepkiewicz","year":"2015","journal-title":"Circ Heart Fail"},{"key":"key\n\t\t\t\t2019022006303550800_key327-B32","doi-asserted-by":"crossref","first-page":"8218","DOI":"10.1073\/pnas.1119899109","article-title":"Genome-wide association and functional studies identify the DOT1L gene to be involved in cartilage thickness and hip osteoarthritis","volume":"109","author":"Casta\u00f1o Betancourt","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t2019022006303550800_key327-B33","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cell.2016.12.039","article-title":"Understanding the intersections between metabolism and cancer biology","volume":"168","author":"Vander Heiden","year":"2017","journal-title":"Cell"},{"key":"key\n\t\t\t\t2019022006303550800_key327-B34","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1126\/science.aaf6284","article-title":"Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism","volume":"354","author":"Peng","year":"2016","journal-title":"Science"},{"key":"key\n\t\t\t\t2019022006303550800_key327-B35","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bone.2014.10.008","article-title":"Biomechanical properties of bone in a mouse model of Rett syndrome","volume":"71","author":"Kamal","year":"2015","journal-title":"Bone"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/58\/3\/527\/27900754\/key327.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T15:03:50Z","timestamp":1550675030000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/58\/3\/527\/5193739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,20]]},"references-count":35,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,11,20]]},"published-print":{"date-parts":[[2019,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/key327","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,3]]},"published":{"date-parts":[[2018,11,20]]}}}